Background: Mechanistic insight into small-molecule Tau aggregation inhibitors is needed for their advancement as therapeutic agents. Results: Structure-activity relationship analysis identified polarizability as a common descriptor of inhibitor potency. Conclusion: Flat, highly polarizable ligands stabilize soluble oligomeric complexes at the expense of filamentous aggregates. Significance: The findings suggest a basis for rational improvement of ligand potency, whereas maintaining bioavailability.